|
FR21C1059I2
(en)
|
|
PHARMACEUTICAL COMPOSITIONS
|
|
DK3030262T3
(en)
|
|
COMBINED PHARMACEUTICAL COMPOSITION
|
|
DK3181128T3
(en)
|
|
NILOTINIB PHARMACEUTICAL COMPOSITION
|
|
BR112015002738A2
(en)
|
|
compound and pharmaceutical composition
|
|
BR112014028602A2
(en)
|
|
liquid formulation.
|
|
BR112015003259A2
(en)
|
|
compound, pharmaceutical composition, and vaccine composition.
|
|
DK2900645T3
(en)
|
|
HERBICID ACTIVE 3-PHENYLISOXAZOLINE DERIVATIVES
|
|
DK3043778T3
(en)
|
|
PHARMACEUTICAL COMPOSITIONS CONTAINING REFAMETINIB
|
|
DK2897594T3
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
|
CO6940426A2
(en)
|
|
Pharmaceutical formulations
|
|
BR112015002824A2
(en)
|
|
compound, use of a compound, pharmaceutical composition, and combination pharmaceutical product.
|
|
CL2014003283A1
(en)
|
|
Pharmaceutical formulation
|
|
DK2868318T4
(en)
|
|
INJECTIBLE FORMULATION
|
|
DK2854765T3
(en)
|
|
PHARMACEUTICAL PEMETREXED SOLUTION
|
|
BR112016014512A2
(en)
|
|
pemetrexed liquid pharmaceutical formulations
|
|
HK1205683A1
(en)
|
|
Pharmaceutical formulation having improved stability
|
|
CO7091176A2
(en)
|
|
Pharmaceutical diagnosis
|
|
DK3473255T3
(en)
|
|
PHARMACEUTICAL FORMULATION INCLUDING CICLESONIDE
|
|
DK2735305T3
(en)
|
|
Stabilized liquid pharmaceutical preparations
|
|
BR112015002646A2
(en)
|
|
compound and pharmaceutical composition
|
|
DK3003401T3
(en)
|
|
PHARMACEUTICAL PREPARATION
|
|
BR112012021455A2
(en)
|
|
pharmaceutical or nutraceutical formulation.
|
|
BR112014032501A2
(en)
|
|
compound and pharmaceutical composition.
|
|
SMT201600419B
(en)
|
|
PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOLIPIDES
|
|
DK2908836T3
(en)
|
|
Pharmaceutical formulation containing curcuma
|